Preclinical Trials – An Update on Translational Research in ALS

Publisher： Karger

E-ISSN： 1660-2862|2|3-4|215-219

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.2, Iss.3-4, 2006-01, pp. : 215-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Raising standards for preclinical research

By  

Evidence-Based Preclinical Medicine, Vol. 1, Iss. 1, 2014-12 ,pp. : 1-3

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Trials in ALS: What Did We Learn from Recent Trials in Humans?

By  

Neurodegenerative Diseases, Vol. 2, Iss. 3-4, 2006-01 ,pp. : 208-214

Karger

Access to resources Recommend Favorite

Employing Alzheimer Disease Animal Models for Translational Research: Focus on Dietary Components

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-10 ,pp. : 131-134

Karger

Access to resources Recommend Favorite

The relationship between risk of bias criteria, research outcomes, and study sponsorship in a cohort of preclinical thiazolidinedione animal studies: a meta‐analysis

By  

Evidence-Based Preclinical Medicine, Vol. 1, Iss. 1, 2014-12 ,pp. : 11-20

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Norwegian Institute of Public Health Twin Program of Research: An Update

By Harris Jennifer R.  

Twin Research and Human Genetics, Vol. 9, Iss. 6, 2006-12 ,pp. : 858-864

Australian Academic Press

Access to resources Recommend Favorite